Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03484494 · ClinicalTrials.gov registry record · NA

Low Field Magnetic Stimulation: Imaging Biomarkers in Geriatric Bipolar Depression

A NA study of Bipolar Disorder and Bipolar Depression, sponsored by Mclean Hospital.

Active
Registry status
NA
Development phase
40
Enrollment target
1
Study location

NCT03484494 is a NA study of Bipolar Disorder and Bipolar Depression that is active but no longer recruiting, run by Mclean Hospital. The registered enrollment target is 40 participants, below the 332-participant average among 162 other Bipolar Disorder trials with a reported enrollment target (88% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03484494, a NA study of Bipolar Disorder and Bipolar Depression, is active but no longer recruiting, sponsored by Mclean Hospital.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
40 participants
Enrollment target
1
Study location

Study Summary

The protocol involves functional Magnetic Resonance Imaging acquisitions immediately before and after Low Field Magnetic Stimulation treatment on two separate days in a sham controlled, randomized trial, in order to assess the physiologic effects of Low Field Magnetic Stimulation on brain function in a geriatric population with bipolar depression.

Interventions

  • DEVICE Low Field Magnetic Stimulation

Study Locations (1)

Massachusetts

  • McLean Hospital - Belmont

Trial Details

FieldValue
Enrollment Target 40 participants
Start Date 2018-05-29
Est. Completion 2026-07-21
Phase NA

Sponsor

Mclean Hospital

140 total trials

What the Registry Record Tells You About NCT03484494

The ClinicalTrials.gov registry entry for NCT03484494 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 332-participant average among 162 other Bipolar Disorder trials with a reported enrollment target (88% lower). The listed sponsor is Mclean Hospital, which has 140 total studies on file at ClinicalTrials.gov.

The record links to 4 conditions, with Bipolar Disorder appearing as the primary indexed condition, and to 1 intervention - of which Low Field Magnetic Stimulation is the first listed.

NCT03484494 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.

Frequently Asked Questions

What is clinical trial NCT03484494 about?

NCT03484494 is a clinical study titled "Low Field Magnetic Stimulation: Imaging Biomarkers in Geriatric Bipolar Depression". The protocol involves functional Magnetic Resonance Imaging acquisitions immediately before and after Low Field Magnetic Stimulation treatment on two separate days in a sham controlled, randomized trial, in order to assess the physiologic effects of Low Field Magnetic Stimulation on brain function i...

What is the current status of trial NCT03484494?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 40 participants. The study started on 2018-05-29. Estimated completion is 2026-07-21.

What conditions does trial NCT03484494 study?

This clinical trial studies the following conditions: Bipolar Disorder, Bipolar Depression, Bipolar I Disorder, Bipolar II Disorder.

What interventions are being tested in trial NCT03484494?

The interventions under investigation include: Low Field Magnetic Stimulation (DEVICE).

Who is sponsoring clinical trial NCT03484494?

This trial is sponsored by Mclean Hospital, which has 140 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03484494 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Bipolar Disorder

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.